Heterotopic Ossification Table 5 Radiation Therapy in Treatment of Heterotopic Ossification Post SCI

Author Year
Country
Score
Research Design
Total Sample Size

Methods

Results

Sautter-Bihl et al. 2001
Germany
Downs & Black score =12
Case series
N=52

Population: Mean age = 33 yrs; Gender: males = 44, females = 8;
Treatment: Patients received single dose of radiotherapy between 2 to 10 Gy through a linear accelerator at 6-8 MV photons.
Outcome Measures: Efficacy, Brooker score, adverse effects.

  1. Prevention of HO was seen in 71%  (41 primarily treated and 9 resected) joints.
  2. Radiotherapy treatment did not result in a regression of the Brooker score in any patient.
  3. An increase in two Brooker score grades was seen in two joints (1 knee, 1 hip).
  4. No adverse effects due to therapy occurred.
  5. 16 of 32 hips treated only with radiotherapy (50%) did not show any abnormalities on follow-up.
  6. No progression of HO was noted in 30/36 subjects (83%).
  7. Reossification after therapy, which led to a decrease in joint mobility was noted in 3 subjects.

Sautter-Bihl et al. 2000
Germany
Downs & Black score =9
Case series
N=36

Population: Age = 17-59 yrs; Gender: males = 32, females = 4; Follow-up = 4-98 months.
Treatment: 25/36 subjects received 10 Gy in fraction of 2-2.5Gy, while 4 pts received higher doses. In phase 2- 7 subjects received a single does of irradiation with 8Gy. In total 46 joints were irradiated.
Outcome Measures: Progression of HO, complications.

No statistically significant results reported.

  1. 16 of the 32 hips treated with radiotherapy only did not show any abnormalities on F/U
  2. No progression of HO was noted in 30/36 subjects.
  3. Reossification after therapy, which led to a decrease in joint mobility, was noted in 3 subjects.

Note: F/U=follow-up